Add to Favourites
To login click here
The xVFA platform utilizes a multiplexed array of immunoreactive peptide epitopes and low-cost paper-based sensors to provide a single-tier, rapid, and accessible platform for serologic testing of Lyme disease. This platform offers improved specificity and reduced cost compared to traditional two-tier assays using recombinant proteins.
